Rose, Louise <br/><br/>
Recombinant factor VIIa: review of current "off license" indications and implications for practice.  [electronic resource] 

 -  AACN advanced critical care   
 - 141-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1559-7768 
<br/><br/><label>Standard No.: </label>10.4037/15597768-2007-2006  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Cardiac Surgical Procedures--adverse effects<br/>Critical Care--methods<br/>Drug Labeling<br/>Drug Monitoring<br/>Drug and Narcotic Control<br/>Erythrocyte Transfusion<br/>Evidence-Based Medicine<br/>Factor VII--pharmacology<br/>Factor VIIa<br/>Hemorrhage--drug therapy<br/>Hospital Mortality<br/>Humans<br/>Liver Failure--complications<br/>Nurse's Role<br/>Patient Selection<br/>Randomized Controlled Trials as Topic<br/>Recombinant Proteins--pharmacology<br/>Safety<br/>Treatment Outcome<br/>United States--epidemiology<br/>Wounds and Injuries--complications